NCT06603402View on ClinicalTrials.gov

Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC

PHASE2RecruitingINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

August 24, 2023

Primary Completion Date

March 1, 2025

Study Completion Date

September 1, 2025

Conditions
Esophageal Squamous Cell Carcinoma (ESCC)Immunotherapy
Interventions
RADIATION

low-dose involved-field radiotherapy combined with immunochemotherapy

low-dose involved-field radiotherapy combined with immunochemotherapy

Trial Locations (1)

610041

RECRUITING

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors
lead

Sichuan University

OTHER